Antonio Herce
InvestorDirector at Inveready Technology Investment Group
Barcelona, Spain
Writes $300K – $1.8M checks · typically $875K
About
Investment Director who joined Inveready in 2019 and has taken part in investments across more than 20 companies plus several divestments, handling deal analysis, due diligence coordination, and portfolio management. He sits on the boards of Nanoligent, Atlas Molecular Pharma, Galgo Medical, and StereoDive, and previously worked in technology transfer and business development. He holds a Biotechnology degree and an MSc in Management of Biomedical Companies from the University of Barcelona.
Contact· self-published, not guessed
Invests in
BiotechMedical Devices
Experience
- InvereadyDirector - Life Sciencescurrent2023 — presentBarcelona, Cataluña, España
- InvereadyAssociate - Life Sciences2020 — 2023Barcelona, Cataluña, España
- InvereadyInvestment Analyst - Life Sciences2019 — 2020Barcelona y alrededores, España
- NanoligentBoard Membercurrent2025 — presentBarcelona, Cataluña, España
- ATLAS MOLECULAR PHARMABoard Membercurrent2022 — presentDerio
- Galgo Medical SLBoard Membercurrent2024 — present
- aptaTargetsBoard Observercurrent2020 — presentMadrid, Comunidad de Madrid, España
- MiMark diagnosticsBoard Observercurrent2023 — present
- AmacaTheraBoard Observercurrent2020 — presentToronto, Ontario, Canadá
- OXOLIFEBoard Observer2020 — 2026Barcellona
- OncostellaeBoard Observer2020 — 2025Santiago de Compostela, Galicia / Galiza, España
- InnoUp FarmaBoard Observer2020 — 2025Pamplona/Iruña, Comunidad Foral de Navarra, España
- Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de RecercaInnovation & Tech Transfer Project Manager2017 — 2019Barcelona y alrededores, España
- IMIBICTech Transfer & Innovation Manager2016 — 2017Córdoba, España
- BionureBusiness Development2016Barcelona y alrededores, España
Skills & more
Team Work11Trabajo en equipo13Management10Dirección8Communicative skills7Teamwork2Habilidades comunicativas5Business development2Biotech7R&D5Patentes2Ciencias naturales12
+12 more
BiotecnologíaIndustria farmacéuticaI+DCienciasPharmaEstrategia empresarialPharmaceutical IndustryInvestigación de mercadoMarketingDesarrollo de negocioInglésEspañolLanguages Catalán · Español · Inglés
From Antonio's professional profile.
Investments
Board seats
Atlas Molecular PharmaGalgo MedicalNanoligentStereoDive
Per the firm's website.
Colleagues at Inveready Technology Investment Group
Adrià Roca
Director at Inveready Technology Investment Group
Adrián Macho
Associate at Inveready Technology Investment Group
Alain Marxuach
Associate at Inveready Technology Investment Group
Alba Fernández
Analyst at Inveready Technology Investment Group
Alejandro López
Analyst at Inveready Technology Investment Group
Ana Martínez
General Partner at Inveready Technology Investment Group
Andrea Amador
Compliance Manager at Inveready Technology Investment Group
Andreu Perdigó
Associate at Inveready Technology Investment Group
Network4
Pablo GonzalezScout
Investor at Cometa
Borja Ballesté Pérez de Olaguer
Investor at Inveready Technology Investment Group
Carlos Conti
Managing Partner at Inveready Technology Investment Group
Carlos Moser Ferrer
Principal at Inveready Technology Investment Group
Investors connected to Antonio in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Antonio Herce?
- Investment Director who joined Inveready in 2019 and has taken part in investments across more than 20 companies plus several divestments, handling deal analysis, due diligence coordination, and portfolio management. He sits on the boards of Nanoligent, Atlas Molecular Pharma, Galgo Medical, and StereoDive, and previously worked in technology transfer and business development. He holds a Biotechnology degree and an MSc in Management of Biomedical Companies from the University of Barcelona.
- Where does Antonio Herce work?
- Antonio Herce is Director at Inveready Technology Investment Group.
- What does Antonio Herce invest in?
- Antonio Herce invests in Biotech, Medical Devices.
- What check size does Antonio Herce write?
- Antonio Herce typically writes checks of $300K – $1.8M.
- What boards does Antonio Herce sit on?
- Antonio Herce holds tracked board seats at Atlas Molecular Pharma, Galgo Medical, Nanoligent, StereoDive.
- Where did Antonio Herce go to school?
- Antonio Herce studied at Universitat de Barcelona (Master in Biotech and Biomedicine Business Management); Universitat de Lleida (Bsc. Biotechnology, Biotech and life sciences).
Same school
Also attended Universitat de Barcelona107
Santiago ReganDirector of Business Development at Redpoint VenturesAndrea AmadorCompliance Manager at Inveready Technology Investment GroupNelson CardonaController at Inveready Technology Investment GroupJosep Maria EcharriManaging Partner & CEO at Inveready Technology Investment GroupMar FernándezMarketing & Communications Manager at Inveready Technology Investment GroupMartina MilàAnalyst at Inveready Technology Investment Group
+ 101 more
